University of California San Francisco

Kenzo Hirose headshot large
Kenzo
Hirose
MD

Associate Professor of Surgery
Division of Surgical Oncology
Director,  General Surgery Residency Program

Address

550 16th Street, #6409
San Francisco, CA 94158
United States

Email: [email protected]
Phone: 415-502-1978

Biography

Dr. Kenzo Hirose is a general surgeon specializing in benign and malignant conditions of the liver, pancreas and bile duct. He has a special interest in minimally invasive surgical techniques and conducts research in patient outcomes after surgery.   

Dr. Kenzo Hirose received his medical degree from Harvard Medical school. He did his residency in general surgery at the University of California, San Francisco and his Hepatopancreatobiliary Fellowship at the Cleveland Clinic. 

 

 

Education

Institution Degree Dept or School End Date
Cleveland Clinic Education Foundation Fellowship 2008
UCSF Medical Center Residency 2006
Harvard School of Medicine 1999

Board Certifications

American Board of Surgery

Clinical Expertise

Bile Duct Injuries
Bile Duct Strictures
Bile Duct Cancer (Cholangiocarcinoma)
Gastrointestinal Carcinoid Tumor
Gastrointestinal Stromal Tumor (GIST)
Choledochal Cysts
Liver Cancer (Hepatocellular Carcinoma)
Minimally Invasive Liver & Pancreas Surgery
Pancreatic Cancer
Pancreatic Cysts
Soft Tissue Sarcomas
Liver Cysts
Liver Metastases
Gallbladder Cancer
Stomach (Gastric) Cancer
Pancreatic Neuroendocrine (Islet Cell) Tumors
Bridging Therapies to Downstage HCC pre-Liver Transplant

Program Affiliations

Hepatobiliary and Pancreas Surgery Program

 

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 102
  1. Promoting Resident Education Priorities With an Acute Care Surgery Service Dashboard.
    Trang K, Pierce L, Wick EC, Vu L, Dicker R, Boeck MA, Garber K, Hirose K| | PubMed
  2. ASO Visual Abstract: Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV| | PubMed
  3. Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC).
    Yin H, Romero-Hernandez F, Ganjouei AA, Wang JJ, Brown A, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Wilhelm A, Peng JS, Alseidi A, Adam MA| | PubMed
  4. Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients.
    Hoffman D, Ganjouei AA, Hernandez FR, Ifuku K, Miller P, Glencer A, Corvera C, Kirkwood K, Alseidi A, Adam M, Maker A, Hirose K, Hirose R, Nakakura EK| | PubMed
  5. ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK| | PubMed
  6. Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV| | PubMed
  7. Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
    Parikh AR, Chee BH, Tsai J, Rich TA, Price KS, Patel SA, Zhang L, Ibrahim F, Esquivel M, Van Seventer EE, Jarnagin JX, Raymond VM, Corvera CU, Hirose K, Nakakura EK, Corcoran RB, Van Loon K, Atreya CE| | PubMed
  8. Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK| | PubMed
  9. Long-Term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors.
    Yogo A, Paciorek A, Kasai Y, Moon F, Hirose K, Corvera CU, Bergsland EK, Nakakura EK| | PubMed
  10. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
    Wong P, Wisneski AD, Tsai KK, Chang TT, Hirose K, Nakakura EK, Daud AI, Maker AV, Corvera CU| | PubMed
  11. Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases.
    Pollini T, Tran T, Wong P, Adam MA, Alseidi A, Corvera C, Hirose K, Nakakura E, Warren R, Maker VK, Maker AV| | PubMed
  12. A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data.
    Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  13. ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA| | PubMed
  14. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA| | PubMed
  15. Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data.
    Tbeileh N, Timmerman L, Mattis AN, Toriguchi K, Kasai Y, Corvera C, Nakakura E, Hirose K, Donner DB, Warren RS, Karelehto E| | PubMed
  16. Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy.
    Lin JJ, Conroy PC, Romero-Hernandez F, Yilma M, Feng J, Hirose K, Nakakura E, Maker AV, Corvera C, Kirkwood K, Alseidi A, Adam MA| | PubMed
  17. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.
    Calthorpe L, Romero-Hernandez F, Miller P, Conroy PC, Hirose K, Kim A, Kirkwood K, Nakakura E, Corvera C, Maker AV, Alseidi A, Adam MA| | PubMed
  18. Implementation, evaluation, and modification of a near-peer learning group in graduate surgical education.
    Conroy PC, Mohamedaly S, Karimzada M, Brian R, Im C, Hernandez S, Roman S, Hirose K, Mukhtar R, Kirkwood K, O'Sullivan P, Alseidi A| | PubMed
  19. Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?
    Miller PN, Romero-Hernandez F, Conroy P, Calthorpe L, Yilma M, Mohamedaly S, Kelly YM, Feng J, Hirose K, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA| | PubMed
  20. Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery.
    Romero-Hernandez F, Mohamedaly S, Miller P, Rodriguez N, Calthorpe L, Conroy PC, Ganjouei AA, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  21. Using Electronic Health Record Meta-Data to Identify Variation in Trainee Progress Note Writing Patterns: Opportunity to Enhance Systems-Based Care.
    Trang K, Pierce L, Wick EC, Hirose K| | PubMed
  22. Emotional Regulation in Surgery: Fostering Well-Being, Performance, and Leadership.
    Greenberg AL, Sullins VF, Donahue TR, Sundaram VM, Saldinger PF, Divino CM, Anton NE, Stefanidis D, Reilly LM, Egan RJ, Beals CKJ, Riall TS, Duh QY, Mukhtar RA, Hirose K, Lebares CC| | PubMed
  23. ASO Visual Abstract: Determining Hospital Volume Threshold for the Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  24. Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA| | PubMed
  25. Estimation of Surgical Resident Duty Hours and Workload in Real Time Using Electronic Health Record Data.
    Lin JA, Pierce L, Murray SG, Soleimani H, Wick EC, Sosa JA, Hirose K| | PubMed
  26. Burden of Ionizing Radiation in the Diagnosis and Management of Necrotizing Pancreatitis.
    Thiruvengadam NR, Miranda J, Kim C, Behr S, Corvera C, Dai SC, Kirkwood K, Harris HW, Hirose K, Nakakura E, Ostroff JW, Kochman ML, Arain MA| | PubMed
  27. Minimally Invasive Surgery for Ileal Neuroendocrine Tumors.
    Mahuron KM, Kasai Y, Javeed ZA, Bergsland EK, Hirose K, Corvera CU, Nakakura EK| | PubMed
  28. How COVID-19 inspired surgical residents to rethink educational programs.
    Brian R, Stock P, Syed S, Hirose K, Reilly L, O'Sullivan P| | PubMed
  29. Contemporary Management of Hepatic Cyst Disease: Techniques and Outcomes at a Tertiary Hepatobiliary Center.
    Gomez A, Wisneski AD, Luu HY, Hirose K, Roberts JP, Hirose R, Freise CE, Nakakura EK, Corvera CU| | PubMed
  30. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.
    Wisneski AD, Jin C, Huang CY, Warren R, Hirose K, Nakakura EK, Corvera CU| | PubMed
  31. Ampullary stenosis and choledocholithiasis post Roux-En-Y gastric bypass: challenges of biliary access and intervention.
    Wisneski AD, Carter J, Nakakura EK, Posselt A, Rogers SJ, Cello JP, Arain M, Kirkwood KS, Hirose K, Stewart L, Corvera CU| | PubMed
  32. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors.
    Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK| | PubMed
  33. Adopting best practices in post-operative analgesia prescribing in a safety-net hospital: Residents as a conduit to change.
    Bongiovanni T, Hansen K, Lancaster E, O'Sullivan P, Hirose K, Wick E| | PubMed
  34. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
    Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK| | PubMed
  35. Variability in Opioid-Prescribing Patterns in Endocrine Surgery and Discordance With Patient Use.
    Lancaster E, Inglis-Arkell C, Hirose K, Seib CD, Wick E, Sosa JA, Duh QY| | PubMed
  36. Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors.
    Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK| | PubMed
  37. Residents as Key Effectors of Change in Improving Opioid Prescribing Behavior.
    Lancaster E, Bongiovanni T, Lin J, Croci R, Wick E, Hirose K| | PubMed
  38. Prevalence and predictors of pain and opioid analgesic use following total pancreatectomy with islet autotransplantation for pancreatitis.
    Moran RA, Klapheke R, John GK, Devlin S, Warren D, Desai N, Sun Z, Walsh C, Kalyani RR, Hall E, Stein EM, Kalloo AN, Zaheer A, Hirose K, Makary MA, Singh VK| | PubMed
  39. Laparoscopic Total Pancreatectomy With Islet Autotransplantation and Intraoperative Islet Separation as a Treatment for Patients With Chronic Pancreatitis.
    Fan CJ, Hirose K, Walsh CM, Quartuccio M, Desai NM, Singh VK, Kalyani RR, Warren DS, Sun Z, Hanna MN, Makary MA| | PubMed
  40. Duodenal and Ampullary Carcinoid Tumors: Size Predicts Necessity for Lymphadenectomy.
    Dogeas E, Cameron JL, Wolfgang CL, Hirose K, Hruban RH, Makary MA, Pawlik TA, Choti MA| | PubMed
  41. Glycemic Predictors of Insulin Independence After Total Pancreatectomy With Islet Autotransplantation.
    Quartuccio M, Hall E, Singh V, Makary MA, Hirose K, Desai N, Walsh C, Warren D, Sun Z, Stein E, Kalyani RR| | PubMed
  42. Chronic Gastrointestinal Dysmotility and Pain Following Total Pancreatectomy with Islet Autotransplantation for Chronic Pancreatitis.
    John GK, Singh VK, Moran RA, Warren D, Sun Z, Desai N, Walsh C, Kalyani RR, Hall E, Hirose K, Makary MA, Stein EM| | PubMed
  43. Ileus is a predictor of local infection in patients with acute necrotizing pancreatitis.
    Moran RA, Jalaly NY, Kamal A, Rao S, Klapheke R, James TW, Thiruvengadam SK, Makary MA, Hirose K, Kumbhari V, Stein EM, Khashab MA, Lennon AM, Kalloo AN, Zaheer A, Hernaez R, Singh VK| | PubMed
  44. A Contemporary Evaluation of the Cause of Death and Long-Term Quality of Life After Total Pancreatectomy.
    Wu W, Dodson R, Makary MA, Weiss MJ, Hirose K, Cameron JL, Ahuja N, Pawlik TM, Wolfgang CL, He J| | PubMed
  45. Surgical approaches to chronic pancreatitis: indications and imaging findings.
    Hafezi-Nejad N, Singh VK, Johnson SI, Makary MA, Hirose K, Fishman EK, Zaheer A| | PubMed
  46. A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy.
    Poruk KE, Lin JA, Cooper MA, He J, Makary MA, Hirose K, Cameron JL, Pawlik TM, Wolfgang CL, Eckhauser F, Weiss MJ| | PubMed
  47. A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts.
    Masica DL, Dal Molin M, Wolfgang CL, Tomita T, Ostovaneh MR, Blackford A, Moran RA, Law JK, Barkley T, Goggins M, Irene Canto M, Pittman M, Eshleman JR, Ali SZ, Fishman EK, Kamel IR, Raman SP, Zaheer A, Ahuja N, Makary MA, Weiss MJ, Hirose K, Cameron JL, Rezaee N, He J, Joon Ahn Y, Wu W, Wang Y, Springer S, Diaz LL, Papadopoulos N, Hruban RH, Kinzler KW, Vogelstein B, Karchin R, Lennon AM| | PubMed
  48. Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach?
    Peters NA, Javed AA, Cameron JL, Makary MA, Hirose K, Pawlik TM, He J, Wolfgang CL, Weiss MJ| | PubMed
  49. Predictors of Post-Operative Pain Relief in Patients with Chronic Pancreatitis Undergoing the Frey or Whipple Procedure.
    Sinha A, Patel YA, Cruise M, Matsukuma K, Zaheer A, Afghani E, Yadav D, Makary MA, Hirose K, Andersen DK, Singh VK| | PubMed
  50. Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer.
    Choti MA, Thomas M, Wong SL, Eaddy M, Pawlik TM, Hirose K, Weiss MJ, Kish J, Green MR| | PubMed
  51. Postoperative Omental Infarct After Distal Pancreatectomy: Appearance, Etiology Management, and Review of Literature.
    Javed AA, Bagante F, Hruban RH, Weiss MJ, Makary MA, Hirose K, Cameron JL, Wolfgang CL, Fishman EK| | PubMed
  52. Effect of surgeon and anesthesiologist volume on surgical outcomes.
    Gani F, Kim Y, Weiss MJ, Makary MA, Wolfgang CL, Hirose K, Cameron JL, Wasey JO, Frank SM, Pawlik TM| | PubMed
  53. A combination of molecular markers and clinical features improve the classification of pancreatic cysts.
    Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, Kinde I, Blackford A, Raman SP, Wolfgang CL, Tomita T, Niknafs N, Douville C, Ptak J, Dobbyn L, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Cummings OW, Brand RE, Zeh HJ, Singhi AD, Scarpa A, Salvia R, Malleo G, Zamboni G, Falconi M, Jang JY, Kim SW, Kwon W, Hong SM, Song KB, Kim SC, Swan N, Murphy J, Geoghegan J, Brugge W, Fernandez-Del Castillo C, Mino-Kenudson M, Schulick R, Edil BH, Adsay V, Paulino J, van Hooft J, Yachida S, Nara S, Hiraoka N, Yamao K, Hijioka S, van der Merwe S, Goggins M, Canto MI, Ahuja N, Hirose K, Makary M, Weiss MJ, Cameron J, Pittman M, Eshleman JR, Diaz LA, Papadopoulos N, Kinzler KW, Karchin R, Hruban RH, Vogelstein B, Lennon AM| | PubMed
  54. National trends with a laparoscopic liver resection: results from a population-based analysis.
    He J, Amini N, Spolverato G, Hirose K, Makary M, Wolfgang CL, Weiss MJ, Pawlik TM| | PubMed
  55. Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy.
    Hicks CW, Tosoian JJ, Craig-Schapiro R, Valero V, Cameron JL, Eckhauser FE, Hirose K, Makary MA, Pawlik TM, Ahuja N, Weiss MJ, Wolfgang CL| | PubMed
  56. The impact of resident involvement on surgical outcomes among patients undergoing hepatic and pancreatic resections.
    Ejaz A, Spolverato G, Kim Y, Wolfgang CL, Hirose K, Weiss M, Makary MA, Pawlik TM| | PubMed
  57. Delayed Gastric Emptying (DGE) Following Total Pancreatectomy with Islet Auto Transplantation in Patients with Chronic Pancreatitis.
    John GK, Singh VK, Pasricha PJ, Sinha A, Afghani E, Warren D, Sun Z, Desai N, Walsh C, Kalyani RR, Hall E, Hirose K, Makary MA, Stein EM| | PubMed
  58. National trends in the use of surgery for benign hepatic tumors in the United States.
    Kim Y, Amini N, He J, Margonis GA, Weiss M, Wolfgang CL, Makary M, Hirose K, Spolverato G, Pawlik TM| | PubMed
  59. Tracking early readmission after pancreatectomy to index and nonindex institutions: a more accurate assessment of readmission.
    Tosoian JJ, Hicks CW, Cameron JL, Valero V, Eckhauser FE, Hirose K, Makary MA, Pawlik TM, Ahuja N, Weiss MJ, Wolfgang CL| | PubMed
  60. Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms.
    Lennon AM, Victor D, Zaheer A, Ostovaneh MR, Jeh J, Law JK, Rezaee N, Molin MD, Ahn YJ, Wu W, Khashab MA, Girotra M, Ahuja N, Makary MA, Weiss MJ, Hirose K, Goggins M, Hruban RH, Cameron A, Wolfgang CL, Singh VK, Gurakar A| | PubMed
  61. Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors.
    Valero V, Amini N, Spolverato G, Weiss MJ, Hirose K, Dagher NN, Wolfgang CL, Cameron AA, Philosophe B, Kamel IR, Pawlik TM| | PubMed
  62. Hospital volume and patient outcomes in hepato-pancreatico-biliary surgery: is assessing differences in mortality enough?
    Schneider EB, Ejaz A, Spolverato G, Hirose K, Makary MA, Wolfgang CL, Ahuja N, Weiss M, Pawlik TM| | PubMed
  63. A population-based evaluation of severity and mortality among transferred patients with acute pancreatitis.
    Anand G, Hutfless SM, Akshintala VS, Khashab MA, Lennon AM, Makary MA, Hirose K, Andersen DK, Kalloo AN, Singh VK| | PubMed
  64. A comparison of open and minimally invasive surgery for hepatic and pancreatic resections using the Nationwide Inpatient Sample.
    Ejaz A, Sachs T, He J, Spolverato G, Hirose K, Ahuja N, Wolfgang CL, Makary MA, Weiss M, Pawlik TM| | PubMed
  65. A single institutional comparison of endoscopic and open abdominal component separation.
    Azoury SC, Dhanasopon AP, Hui X, De La Cruz C, Tuffaha SH, Sacks JM, Hirose K, Magnuson TH, Liao C, Lovins M, Schweitzer MA, Nguyen HT| | PubMed
  66. Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons.
    Weiss MJ, Kim Y, Ejaz A, Spolverato G, Haut ER, Hirose K, Wolfgang CL, Choti MA, Pawlik TM| | PubMed
  67. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study.
    Lennon AM, Manos LL, Hruban RH, Ali SZ, Fishman EK, Kamel IR, Raman SP, Zaheer A, Hutfless S, Salamone A, Kiswani V, Ahuja N, Makary MA, Weiss MJ, Hirose K, Goggins M, Wolfgang CL| | PubMed
  68. Readmission incidence and associated factors after a hepatic resection at a major hepato-pancreatico-biliary academic centre.
    Spolverato G, Ejaz A, Kim Y, Weiss M, Wolfgang CL, Hirose K, Pawlik TM| | PubMed
  69. Duty hours and perceived competence in surgery: are interns ready?
    Lindeman BM, Sacks BC, Hirose K, Lipsett PA| | PubMed
  70. Assessing the experience in complex hepatopancreatobiliary surgery among graduating chief residents: is the operative experience enough?
    Sachs TE, Ejaz A, Weiss M, Spolverato G, Ahuja N, Makary MA, Wolfgang CL, Hirose K, Pawlik TM| | PubMed
  71. Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases.
    Dogeas E, Karagkounis G, Heaphy CM, Hirose K, Pawlik TM, Wolfgang CL, Meeker A, Hruban RH, Cameron JL, Choti MA| | PubMed
  72. Defining incidence and risk factors of venous thromboemolism after hepatectomy.
    Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M, Johnston FM, Kheng M, Kheng M, Hirose K, Wolfgang CL, Haut E, Pawlik TM| | PubMed
  73. Trends and risk factors for transfusion in hepatopancreatobiliary surgery.
    Lucas DJ, Schexneider KI, Weiss M, Wolfgang CL, Frank SM, Hirose K, Ahuja N, Makary M, Cameron JL, Pawlik TM| | PubMed
  74. Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States.
    Hyder O, Dodson RM, Nathan H, Schneider EB, Weiss MJ, Cameron JL, Choti MA, Makary MA, Hirose K, Wolfgang CL, Herman JM, Pawlik TM| | PubMed
  75. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
    Nathan H, Hyder O, Mayo SC, Hirose K, Wolfgang CL, Choti MA, Pawlik TM| | PubMed
  76. A randomized, prospective, double-blind, placebo-controlled trial of the effect of diltiazem gel on pain after hemorrhoidectomy.
    Sugimoto T, Tsunoda A, Kano N, Kashiwagura Y, Hirose K, Sasaki T| | PubMed
  77. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases.
    Karagkounis G, Torbenson MS, Daniel HD, Azad NS, Diaz LA, Donehower RC, Hirose K, Ahuja N, Pawlik TM, Choti MA| | PubMed
  78. Multifaceted longitudinal study of surgical resident education, quality of life, and patient care before and after July 2011.
    Lindeman BM, Sacks BC, Hirose K, Lipsett PA| | PubMed
  79. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm?
    He J, Cameron JL, Ahuja N, Makary MA, Hirose K, Choti MA, Schulick RD, Hruban RH, Pawlik TM, Wolfgang CL| | PubMed
  80. Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma.
    Nathan H, Segev DL, Bridges JF, Massie AB, Cameron AM, Hirose K, Schulick RD, Choti MA, Pawlik TM| | PubMed
  81. Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies.
    Schneider EB, Hyder O, Wolfgang CL, Hirose K, Choti MA, Makary MA, Herman JM, Cameron JL, Pawlik TM| | PubMed
  82. Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis.
    Bhayani NH, Hyder O, Frederick W, Schulick RD, Wolgang CL, Hirose K, Edil B, Herman JM, Choti MA, Pawlik TM| | PubMed
  83. Improvements in quality of life after surgery for benign hepatic tumors: Results from a dual center analysis.
    Kneuertz PJ, Marsh JW, de Jong MC, Covert K, Hyder O, Hirose K, Schulick RD, Choti MA, Geller DA, Pawlik TM| | PubMed
  84. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma.
    Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D, Makary M, Hirose K, Edil B, Choti MA, Herman J, Cameron JL, Wolfgang CL, Pawlik TM| | PubMed
  85. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer.
    Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O, Wolfgang CL, Aldrighetti L, Crawford M, Choti MA, Pawlik TM| | PubMed
  86. Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies.
    Peng PD, Hyder O, Bloomston M, Marques H, Corona-Villalobos C, Dixon E, Pulitano C, Hirose K, Schulick RD, Barroso E, Aldrighetti L, Choti M, Shen F, Kamel I, Geschwind JF, Pawlik TM| | PubMed
  87. Readmission rates and cost following colorectal surgery.
    Wick EC, Shore AD, Hirose K, Ibrahim AM, Gearhart SL, Efron J, Weiner JP, Makary MA| | PubMed
  88. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent.
    Mayo SC, Nathan H, Cameron JL, Olino K, Edil BH, Herman JM, Hirose K, Schulick RD, Choti MA, Wolfgang CL, Pawlik TM| | PubMed
  89. Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience.
    Kneuertz PJ, Cunningham SC, Cameron JL, Torrez S, Tapazoglou N, Herman JM, Makary MA, Eckhauser F, Wang J, Hirose K, Edil BH, Choti MA, Schulick RD, Wolfgang CL, Pawlik TM| | PubMed
  90. National trends in surgical procedures for hepatocellular carcinoma: 1998-2008.
    Nathan H, Segev DL, Mayo SC, Choti MA, Cameron AM, Wolfgang CL, Hirose K, Edil BH, Schulick RD, Pawlik TM| | PubMed
  91. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome.
    de Jong MC, Hong SM, Augustine MM, Goggins MG, Wolfgang CL, Hirose K, Schulick RD, Choti MA, Anders RA, Pawlik TM| | PubMed
  92. The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma.
    Kamel SI, de Jong MC, Schulick RD, Diaz-Montes TP, Wolfgang CL, Hirose K, Edil BH, Choti MA, Anders RA, Pawlik TM| | PubMed
  93. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion.
    Mayo SC, Shore AD, Nathan H, Edil BH, Hirose K, Anders RA, Wolfgang CL, Schulick RD, Choti MA, Pawlik TM| | PubMed
  94. Surgical site infections and cost in obese patients undergoing colorectal surgery.
    Wick EC, Hirose K, Shore AD, Clark JM, Gearhart SL, Efron J, Makary MA| | PubMed
  95. Pay for obesity? Pay-for-performance metrics neglect increased complication rates and cost for obese patients.
    Hirose K, Shore AD, Wick EC, Weiner JP, Makary MA| | PubMed
  96. Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma.
    de Jong MC, Li F, Cameron JL, Wolfgang CL, Edil BH, Herman JM, Choti MA, Eckhauser F, Hirose K, Schulick RD, Pawlik TM| | PubMed
  97. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis.
    Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, Herman J, Schulick RD, Choti MA, Pawlik TM| | PubMed
  98. Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis.
    de Jong MC, Tsai S, Cameron JL, Wolfgang CL, Hirose K, van Vledder MG, Eckhauser F, Herman JM, Edil BH, Choti MA, Schulick RD, Pawlik TM| | PubMed
  99. Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients?
    Hashimoto K, Miller CM, Quintini C, Aucejo FN, Hirose K, Uso TD, Trenti L, Kelly DM, Winans CG, Vogt DP, Eghtesad B, Fung JJ| | PubMed
  100. Management of suspected pancreatic cystic neoplasms based on cyst size.
    Walsh RM, Vogt DP, Henderson JM, Hirose K, Mason T, Bencsath K, Hammel J, Brown N| | PubMed
  101. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
    Mahajan D, Miller C, Hirose K, McCullough A, Yerian L| | PubMed
  102. Images in clinical medicine. Massive subcutaneous emphysema after tracheal perforation.
    Hirose K, Visser BC| | PubMed